This study investigates the proteomic regulation of BAZ2A in hepatocellular carcinoma (HCC) cells using label-free quantification and LC-MS/MS analysis. The aim is to elucidate the individual and common regulatory roles of BAZ1A and BAZ2A in HCC pathogenesis, providing insights into potential therapeutic targets.